APOSENSE
Aposense (formerly NST) is a clinical-stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo. The company translating the science of Apoptosis (programmed cell death) into personalized patient care in multiple disease categories, including oncology, cardiology, and neurology. Targeting of this important biological process in-vivo opens opportunities for real-time clinical ... imaging of disease activity and targeted therapy. Aposense specializing in the development of novel drugs and utilizing membrane electrical forces for trans-membrane of macromolecule drugs, mainly siRNA. It also developed rationally-designed molecular nano-motors (MNMs), being novel small-molecule chemical entities and its translation into kinetic energy for movement within the hydrophobic membrane core. Aposense was founded in 1996 and is headquartered in Petah Tiqva, HaMerkaz, Israel.
APOSENSE
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
1996-01-01
Address:
Petah Tiqva, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.aposense.com
Total Employee:
11+
Status:
Active
Contact:
+ 972.73.239.7600
Email Addresses:
[email protected]
Total Funding:
22.3 M USD
Technology used in webpage:
Google Maps Person Schema Gravatar Profiles Israeli Server Location
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Phoenix Eagle
Phoenix Eagle is a biopharmaceutical research, development company with a robust product pipeline based on its unique OPAL technology.
Soiken
Soiken is a biomarker and bioassay development and research company.
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Ziegler Meditech Equity Partners
Ziegler Meditech Equity Partners investment in Venture Round - Aposense
Pontifax
Pontifax investment in Venture Round - Aposense
Pontifax
Pontifax investment in Venture Round - Aposense
Polar Investments
Polar Investments investment in Venture Round - Aposense
Technorov Holdings
Technorov Holdings investment in Venture Round - Aposense
Docor International Management
Docor International Management investment in Venture Round - Aposense
Ziegler Meditech Equity Partners
Ziegler Meditech Equity Partners investment in Venture Round - Aposense
Clal Biotechnology Industries
Clal Biotechnology Industries investment in Venture Round - Aposense
Phoenix Insurance
Phoenix Insurance investment in Venture Round - Aposense
Bargal R&D Investment
Bargal R&D Investment investment in Venture Round - Aposense
Official Site Inspections
http://www.aposense.com Semrush global rank: 8.94 M Semrush visits lastest month: 446
- Host name: mail.aposense.com
- IP address: 185.106.129.182
- Location: Israel
- Latitude: 31.5
- Longitude: 34.75
- Timezone: Asia/Jerusalem
More informations about "Aposense"
Aposense - Crunchbase Company Profile & Funding
Aposense specializing in the development of novel drugs and utilizing membrane electrical forces for trans-membrane of macromolecule drugs, mainly siRNA. It also developed rationally …See details»
Aposense - Homepage - Interna
Current developments. The molecular nano motor is here, and ready to transform large-molecule medicine. To maximize the impact of the MNM platform, we’re pursuing multiple partnerships …See details»
Aposense - 2025 Company Profile, Funding & Competitors - Tracxn
Aposense - Molecular imaging and drug development based on apoptosis-based technology. Public Company. Raised a total funding of $16.3M over 2 rounds from 8 investors. Founded by …See details»
Aposense 2025 Company Profile: Valuation, Funding
Aposense General Information Description. Developer of diagnostic and therapeutic drugs based in Petah Tikva, Israel. The company is engaged in …See details»
Aposense Company Profile | Management and Employees List
Aposense is a highly innovative Israeli bio-pharmaceutical company, specializing in development of novel drugs, utilizing membrane electrical forces. Popular Searches. Aposense. aposense …See details»
Aposense - Funding, Financials, Valuation & Investors - Crunchbase
Aposense is a molecular imaging and drug development company, with a pipeline of products, based on its apoptosis-based technology. New. Resources. ... How much funding has this …See details»
Aposense - Israeli Startup | Startup Nation Finder
Jan 9, 2019 Note that you need to have an email in this organization in order to claim the profile. Name* Work Email* (please provide your email in the organization) Position* Notes. Send …See details»
Aposense - Products, Competitors, Financials, Employees, …
Aposense is a biotechnology company focused on the development of drug delivery technologies within the healthcare sector. Use the CB Insights Platform to explore Aposense's full profile. …See details»
Aposense Ltd. (Formerly known as NST NeuroSurvival
Similar Companies: Protein Polymer Technologies Inc. (PPTI) USA n/a n/a Hemagen Diagnostics USA n/a n/a. Ardena Belgium n/a Ardena is a fully integrated Contract Development & …See details»
Aposense - VentureRadar
Aposense for PET, SPECT and MRI based clinical molecular imaging of apoptosis. Therapies based on the targeting of therapeutic agents to apoptosis inflicted tissues. Israel Science and …See details»
Aposense - Devex
Learn more about Aposense's jobs, projects, latest news, contact information and geographical presence. Professor Kornberg served as a director of Teva Pharmaceutical Industries Ltd. …See details»
Aposense - Contacts, Employees, Board Members, Advisors
Aposense is a molecular imaging and drug development company, with a pipeline of products, based on its apoptosis-based technology. ... Experience the new Crunchbase, powered by AI . …See details»
Aposense - Overview, News & Similar companies | ZoomInfo.com
Mar 31, 2021 Bioasis Technologies Inc. and Aposense Enter into a Research Collaboration NEW HAVEN, Conn., March 31, 2021 (GLOBE NEWSWIRE) -- Bioasis Technologies Inc. …See details»
Novel powerhouse to energize drug performance - Nature
Aposense . Yuval Gottenstein, VP, Business Development, Aposense, Petach-Tikva, Israel, Tel: +972 73 239 7601, www.aposense.comSee details»
Aposense Information - RocketReach
Aposense is an innovative biotechnology company that developed a transformational delivery technology for macromolecules. The pioneering technology, named Molecular Nano-Motors …See details»
Aposense - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Aposense is a molecular imaging and drug development company, with a pipeline of products, based on its apoptosis-based technology. New. Resources. Advanced Search. Start Free Trial …See details»
About Aposense Ltd (APOS) - Investing.com
Aposense Ltd. was founded in 1996 and is based in Petah Tikva, Israel. ... We do not allow any sharing of private or personal contact or other information about any individual or organization ...See details»
Aposense Ltd. Secures $10.25 Million Funding Round; Announces …
Nov 4, 2024 Aposense Ltd., a leader in macromolecule transmembrane delivery, today announced that it has secured $10.25 million in a funding round supported by the Bill & …See details»
Aposense - Ziegler
Aposense, Ltd. (fka NeuroSurvival Technologies, Ltd.) has developed a series of molecules that selectively target and accumulate within dying, or apoptotic cells. The molecules, which use …See details»
Aposense - Crunchbase
Aposense is a molecular imaging and drug development company, with a pipeline of products, based on its apoptosis-based technology. Search Crunchbase Start Free TrialSee details»